News
This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
A WOMAN who shed a whopping 6st in just nine months has shared the secret behind not pilling back all the pounds when eating out. Lucy Davies kickstarted her weight loss journey with the popular ...
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...
Sally Love has always enjoyed a drink - but, like many, it was during the Covid pandemic that her alcohol intake began to spiral.
A WOMAN has revealed that she has shed 7kg without the help of Mounjaro. Since becoming available on the NHS earlier this ...
"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
Harvey Jones thought he spotted the Diageo share price going cheap but jumped too soon. Could his bargain buy finally start ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
19h
TipRanks on MSNHims & Hers Health Stock Soars Amid Investor BuzzHims & Hers Health ( ($HIMS) ) has risen by 21.11%. Read on to learn why. Hims & Hers Health has experienced a notable 21.11% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results